ConsumerLab.com uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.

About ConsumerLab.com

Posted March 13, 2020

FDA Finds Problems at 52% of Supplement Manufacturing Sites in U.S. and 42% Abroad

ConsumerLab.com has obtained results of the FDA's inspections in Fiscal Year 2019 (October 1, 2018 - September 30, 2019) of 598 dietary supplement manufacturing facilities in the U.S. and abroad, showing that most -- 51% -- received letters indicating noncompliance with current Good Manufacturing Practices (cGMPs). Manufacturers are required by law to follow cGMPs. Only a small fraction of facilities are inspected by the FDA each year. ConsumerLab.com received the results under the Freedom of Information Act. 

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at www.consumerlab.com/join/